Literature DB >> 7895263

Human microvascular endothelial cell-extracellular matrix interaction in cellular growth state determination.

S R Mallery1, L E Lantry, M C Toms, L C Titterington, B L Hout, G P Brierley, R E Stephens.   

Abstract

We introduce two methods, both of which are based on cellular-extracellular matrix interaction, which will facilitate the study of human microvascular endothelial cells. One method describes the means to obtain a G1 population baseline in human microvascular endothelial cells. Because of the contribution of the extracellular matrix in endothelial cell growth, synchronization in G1 was possible only after the incorporation of angiostatic levels of heparin and hydrocortisone into the extracellular matrix. In the second method, we demonstrate that selective perturbation of human microvascular endothelial cell-extracellular matrix interactions results in the induction of a transitional growth state, between proliferative and differentiated growth states, in human microvascular endothelial cells. In the functional, microtubule formation assays, transitional growth state endothelial cells display rates that are indermediate between those obtained from differentiated and proliferative endothelial cells. Our results demonstrate the importance of the human microvascular endothelial cell-extracellular matrix interaction in the determination of cellular growth state. Our findings also imply that responsiveness of microvascular endothelial cells to their cellular-extracellular matrix environs is highest during the differentiated growth state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895263     DOI: 10.1007/bf00300689

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  30 in total

1.  In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins.

Authors:  J Bauer; M Margolis; C Schreiner; C J Edgell; J Azizkhan; E Lazarowski; R L Juliano
Journal:  J Cell Physiol       Date:  1992-12       Impact factor: 6.384

Review 2.  Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy.

Authors:  D E Ingber
Journal:  Semin Cancer Biol       Date:  1992-04       Impact factor: 15.707

3.  Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration.

Authors:  C T Basson; O Kocher; M D Basson; A Asis; J A Madri
Journal:  J Cell Physiol       Date:  1992-10       Impact factor: 6.384

Review 4.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

5.  An alternative cytoplasmic domain of the integrin beta 3 subunit.

Authors:  T H van Kuppevelt; L R Languino; J O Gailit; S Suzuki; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 6.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

Review 7.  Microcirculation and diabetes.

Authors:  J E Tooke
Journal:  Br Med Bull       Date:  1989-01       Impact factor: 4.291

8.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix.

Authors:  D E Ingber; J Folkman
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Human microvascular endothelial cells use beta 1 and beta 3 integrin receptor complexes to attach to laminin.

Authors:  R H Kramer; Y F Cheng; R Clyman
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.